These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 18220502)

  • 1. Altered glycosylation of proteins in cancer: what is the potential for new anti-tumour strategies.
    Brooks SA; Carter TM; Royle L; Harvey DJ; Fry SA; Kinch C; Dwek RA; Rudd PM
    Anticancer Agents Med Chem; 2008 Jan; 8(1):2-21. PubMed ID: 18220502
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Importance of altered glycoprotein-bound N- and O-glycans for epithelial-to-mesenchymal transition and adhesion of cancer cells.
    Lange T; Samatov TR; Tonevitsky AG; Schumacher U
    Carbohydr Res; 2014 May; 389():39-45. PubMed ID: 24491280
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Harnessing changes in cellular glycosylation in new cancer treatment strategies.
    Dwek MV; Brooks SA
    Curr Cancer Drug Targets; 2004 Aug; 4(5):425-42. PubMed ID: 15320718
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glycosylation in cancer: Selected roles in tumour progression, immune modulation and metastasis.
    Rodrigues JG; Balmaña M; Macedo JA; Poças J; Fernandes Â; de-Freitas-Junior JCM; Pinho SS; Gomes J; Magalhães A; Gomes C; Mereiter S; Reis CA
    Cell Immunol; 2018 Nov; 333():46-57. PubMed ID: 29576316
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glycosylation: a hallmark of cancer?
    Vajaria BN; Patel PS
    Glycoconj J; 2017 Apr; 34(2):147-156. PubMed ID: 27975160
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aberrant protein glycosylation in cancer: implications in targeted therapy.
    Rodrigues JG; Duarte HO; Reis CA; Gomes J
    Biochem Soc Trans; 2021 Apr; 49(2):843-854. PubMed ID: 33704376
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Simple sugars to complex disease--mucin-type O-glycans in cancer.
    Kudelka MR; Ju T; Heimburg-Molinaro J; Cummings RD
    Adv Cancer Res; 2015; 126():53-135. PubMed ID: 25727146
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Short O-GalNAc glycans: regulation and role in tumor development and clinical perspectives.
    Chia J; Goh G; Bard F
    Biochim Biophys Acta; 2016 Aug; 1860(8):1623-39. PubMed ID: 26968459
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of protein glycosylation in cancer metastasis.
    Oliveira-Ferrer L; Legler K; Milde-Langosch K
    Semin Cancer Biol; 2017 Jun; 44():141-152. PubMed ID: 28315783
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The cancer glycome: carbohydrates as mediators of metastasis.
    Glavey SV; Huynh D; Reagan MR; Manier S; Moschetta M; Kawano Y; Roccaro AM; Ghobrial IM; Joshi L; O'Dwyer ME
    Blood Rev; 2015 Jul; 29(4):269-79. PubMed ID: 25636501
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protein glycosylation in gastric and colorectal cancers: Toward cancer detection and targeted therapeutics.
    Ferreira JA; Magalhães A; Gomes J; Peixoto A; Gaiteiro C; Fernandes E; Santos LL; Reis CA
    Cancer Lett; 2017 Feb; 387():32-45. PubMed ID: 26828132
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of the carbohydrates in plasmatic membrane.
    Sprovieri P; Martino G
    Physiol Res; 2018 Mar; 67(1):1-11. PubMed ID: 29137479
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glycosylation markers in cancer.
    Silsirivanit A
    Adv Clin Chem; 2019; 89():189-213. PubMed ID: 30797469
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glycosylation in the Era of Cancer-Targeted Therapy: Where Are We Heading?
    Mereiter S; Balmaña M; Campos D; Gomes J; Reis CA
    Cancer Cell; 2019 Jul; 36(1):6-16. PubMed ID: 31287993
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glycosylation characteristics of colorectal cancer.
    Holst S; Wuhrer M; Rombouts Y
    Adv Cancer Res; 2015; 126():203-56. PubMed ID: 25727149
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor malignancy defined by aberrant glycosylation and sphingo(glyco)lipid metabolism.
    Hakomori S
    Cancer Res; 1996 Dec; 56(23):5309-18. PubMed ID: 8968075
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Highly glycosylated tumour antigens: interactions with the immune system.
    Saeland E; van Kooyk Y
    Biochem Soc Trans; 2011 Jan; 39(1):388-92. PubMed ID: 21265810
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glycosylation in cancer: mechanisms and clinical implications.
    Pinho SS; Reis CA
    Nat Rev Cancer; 2015 Sep; 15(9):540-55. PubMed ID: 26289314
    [TBL] [Abstract][Full Text] [Related]  

  • 19. N-glycoproteins bearing beta1-6 branched oligosaccharides from the A375 human melanoma cell line analysed by tandem mass spectrometry.
    Ochwat D; Hoja-Łukowicz D; Lityńska A
    Melanoma Res; 2004 Dec; 14(6):479-85. PubMed ID: 15577318
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protein glycosylation and diseases: blood and urinary oligosaccharides as markers for diagnosis and therapeutic monitoring.
    Durand G; Seta N
    Clin Chem; 2000 Jun; 46(6 Pt 1):795-805. PubMed ID: 10839767
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.